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Background
Earlier investigations demonstrated that the activity and
function of soluble guanylyl cyclase (sGC) may be
modulated by interacting proteins, such as HSP70,
HSP90, CCTh or PDI. We have also previously demon-
strated that G-protein signaling modulator proteins 1
and 2 (GPSM1, 2) directly interact with the catalytic
region of sGC and attenuate the response of sGC to
activators in cell lysates.
Results
In this report, we provide evidence that vascular function
of sGC is increased in GPSM1-deficient mice. We found
that GPSM1-deficient mice have a lower resting blood
pressure than their wild type counterparts. Intraperito-
neal injection of sGC stimulator BAY 41-2272 elicited a
transient decrease in blood pressure in both strains.
However, GPSM1-/- mice were more sensitive to lower
doses of BAY 41-2272, while the decrease in blood pres-
sure was more profound and more sustained than in wild
type mice. In ex vivo setting, preconstricted aortic rings
from GPSM1-/- mice were more sensitive to acetylcholine
and BAY 41-2272. Western blotting showed similar level
of sGC expression in aortas of both strains. H&E staining
of aorta sections showed no obvious morphologic differ-
ences between these strains of mice. However, aortas
from GPSM1-/- mice sowed a higher level of cGMP accu-
mulated in response to NO donor DEA-NO than from
wild type animals. Unexpectedly, cGMP-degrading activity
was also higher in GPSM1-/- mice. These data indicate
that, at least in conductive vessels, sGC function is upre-
gulated in the absence of GPSM1. These observations are
consistent with previously observed GPSM1-dependent
inhibition of sGC in cellular lysates.
Conclusion
Data presented here clearly indicate that GPSM1 is a
modifier of sGC vascular function. Since GPSM1 is known
to associate with Ga subunit of heterotrimeric G-proteins,
it remains to be determined, if there is any GPSM1-
mediated cross-talk between sGC function and heterotri-
meric G-protein signaling.
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